Burkitt's lymphoma has distinctive clinical and pathological features. Although the disease is endemic in tropical Africa, sporadic cases have been reported from different parts of the world (Weight 1966; Arseneau et al. 1975 ; Al-Attar et al. 1979 ). African and nonendemic cases are histologically identical but clinically somewhat different.
We have recently encountered a five-year-old girl with Burkitt's lymphoma. This has prompted us to investigate Japanese cases of Burkitt's lymphoma reported to date in the Japanese literature.
The purpose of this paper is to review briefly Japanese cans of Brukitt's lymphoma.
MATERIALS AND RESULTS
We have collected twenty-two cases of Burkitt's lymphoma, including ours, from the Japanese literature.
There were 14 males and 8 females. Age range was 1-29 years with a mean age of 9.5 years. The majority (19 patients) were between 1 and 15 years of age. Three patients were older-19, 26 and 29 years. All patients were staged according to the clinical staging criteria by Ziegler et al. (1970) . Of the 22 cases, 5 (23%) were in stage I, 8 (36%) were in stage II, 6 (27%) were in stage III and 3 (14%) were in stage IV.
The sites involved at the time of presentation are shown in Table 1 . Twenty patients presented with facial bone swelling. Of the 20 patients with jaw tumor, 6 had involvement of the maxilla alone, 8 of the mandible alone, while 6 had both maxillary and mandibular involvement. Exophthalmus was associated with jaw tumor in 5 cases. Eight patients presented with abdominal mass and complained mainly of abdominal pain, nausea and vomiting. Of the 3 females with abdominal symptoms, one was found to have ovarian tumor. Neurologic abnormalities were noted on presentation in 4 patients. Three had facial nerve palsy without meningeal signs and one paraplegia. The central nervous system, however, has been involved during the course of the illness in 7 (32%) of the 22 patients. They revealed facial nerve palsy, oculomotor nerve palsy and meningeal signs including headache, nausea and vomiting. Examination of the cerebrospinal fluid showed pleocytosis in 3 patients.
The bone marrow was involved and leukemic transformation was observed in 7 (32%) of the 22 patients during the course of the disease. The antibody titers to Epstein-Barn (EB) virus were determined in 17 patients and only one patient had a significantly higher titer (>2560) ( Table 2) . Thus, the antibody titers to EB virus were comparable to those found in control group. Serum immunoglobulin levels were measured in 7 patients. Two had normal levels and two low levels of IgA, IgG and IgM. Two showed a low level of IgM with normal levels of IgA and IgG. Clinical and anatomic distribution o f sites o f involvement in 22 Japanese Burkitt's lymphoma patients on presentation patients. The mean levels of serum LDH in patients with stages I, II, III and IV were 800, 905, 2738 and 2672 IU Jml, respectively. Thus serum LDH levels were lower in patients with localized disease than those with advanced tumor. Malignant cells were studied for the presence of immunologic surface markers in two patients, in whom monoclonal surface IgM was identified and light chain was of the kappa type, indicating that the neoplastic cells were monoclonal B lymphocytes.
The relation between the clinical stage of the disease on presentation and subsequent survival is shown in Table 3 .
The mean survival of all patients was 3.8 months after diagnosis and no significant differences were found between the stage of the disease and survival.
DISCUSSION
Since Oboshi et al. (1969) reported the first Japanese case of Burkitt's lymphoma in 1969, 22 patients with Burkitt's lymphoma, to our knowledge, have been described in the Japanese literature. We have found that Japanese patients with Burkitt's lymphoma have both similarities and differences in clinicopathological pictures when compared with African and American patients with Burkitt's lymphoma.
The mean age in 22 Japanese patients was 9.5 years, with an 1.8:1 male: female ratio. These mean age and sex distribution pattern are almost similar to those found in African and American patients (Cohen et Levine and Cho 1974) . The central nervous system has been frequently involved and paraplegia is the third most frequent feature in African patients (Wright and Path 1967) . Although paraplegia was uncommon in Japanese patients like American patients, the central nervous system was evidently involved in 32% of the Japanese patients, who revealed facial and/or oculomotor nerve palsies, either alone or combined with meningeal symptoms. While diffuse bone marrow involvement and leukemic transformation are infrequent in African patients (Wright and Path 1967), 32% of the Japanese patients developed leukemic transformation during the course of the illness. The incidence of bone marrow involvement in American patients varied from 26 to 76% (Cohen et al. 1969 ; Levine and Cho 1974) . Pathologic peripheral lymphadenopathy and pleural involvement are reported to occur frequently in American patients (Cohen et al. 1969 ). These manifestations, however, were uncommon in Japanese patients. Similarly, the incidence of involvements of peripheral lymph node and pleura is low in African patients (Wright and Path 1967 ).
An association between EB virus and African Burkitt's lymphoma has been well documented (Henle et al. 1969 ). African patients with Burkitt's lymphoma generally have markedly elevated titers of the anti-EB virus antibody (Henle et al. 1969; Hirshaut et al. 1973 ). In contrast, the titers of antibodies to EB virus in Japanese patients were comparable to those found in control group. In American patients, Levine et al. (1972) reported that there were significantly higher titers of anti-EB virus antibody in American patients as compared with controls, while Hirshaut et al. (1973) described that titers in American cases did not differ significantly from those found in control groups. Arseneau et al. (1975) reported that serum LDH levels were significantly lower in patients with stage I-II than those with stage III-IV, suggesting a good correlation between LDH levels and stage of the disease. In accord with their findings, serum LDH levels were low in Japanese patients with localized disease as compared to those with advanced tumor. Thus, serum LDH levels appear to serve as an indicator of the extent of the disease. The neoplastic cells in most of African and American cases of Burkitt's lymphoma are described to be monoclonal B lymphocytes (Mann et al. 1976) . Similarly, malignant cells from Japanese patients with Burkitt's lymphoma had B cell surface markers.
Chemotherapeutic response is hard to evaluate in Japanese cases because of different regimens used. However, Japanese patients were generally refractory to cytotoxic drugs, including cyclophosphamide, vincristine, methotrexate and cytosine arabinoside, and had a poor prognosis, regardless of the initial stage of the disease. Thus, the mean survival of Japanese patients was short as compared to those of African and American cases (Ziegler et al. 1970; Ziegler 1972; Arseneau et al. 1975; Nkrumah and Perkins 1976) . The explanation for the poor prognosis may be racial, environmental and immunologic factors. Further explorations for these factors will be required to improve the prognosis in Japanese patients.
